Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.75B |
| 2 |
MSLC
Morgan Stanley Pathway Large Cap Equity ETF
MSLC
|
+$2.07B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.75B |
| 4 |
Apple
AAPL
|
+$1.6B |
| 5 |
Tesla
TSLA
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 3 |
Strategy Inc
MSTR
|
+$1.3B |
| 4 |
Shopify
SHOP
|
+$1.14B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.55% |
| 2 | Financials | 11.55% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.08% |
| 5 | Communication Services | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
MBIA
MBI
$260M
| $2.68M | ﹤0.01% |
414,162
-50,414
| -11% | -$260K |
|
|
PFD
4402
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
| $2.67M | ﹤0.01% |
237,967
-13,784
| -5% | -$159K |
|
|
ETNB
4403
DELISTED
89bio
ETNB
| $2.67M | ﹤0.01% |
341,951
-58,287
| -15% | -$480K |
|
4404
VanEck Low Carbon Energy ETF
SMOG
$134M
| $2.67M | ﹤0.01% |
27,090
+131
| +0.5% | +$13.6K |
|
4405
Xenon Pharmaceuticals
XENE
$6.12B
| $2.67M | ﹤0.01% |
68,062
-171,880
| -72% | -$7.11M |
|
|
TBI
4406
Trueblue
TBI
$311M
| $2.67M | ﹤0.01% |
317,436
+53,993
| +20% | +$417K |
|
4407
Quanterix
QTRX
$190M
| $2.67M | ﹤0.01% |
250,820
-57,361
| -19% | -$698K |
|
|
LENZ
4408
LENZ Therapeutics
LENZ
$168M
| $2.66M | ﹤0.01% |
92,284
+41,806
| +83% | +$1.27M |
|
|
MAV
4409
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
| $2.66M | ﹤0.01% |
315,422
-162,496
| -34% | -$1.41M |
|
4410
Aclaris Therapeutics
ACRS
$869M
| $2.66M | ﹤0.01% |
1,071,784
+591,011
| +123% | +$1.47M |
|
4411
VanEck Environmental Services ETF
EVX
$102M
| $2.66M | ﹤0.01% |
77,495
+565
| +0.7% | +$20.7K |
|
4412
Invesco S&P SmallCap Materials ETF
PSCM
$21.6M
| $2.66M | ﹤0.01% |
36,047
+3,124
| +9% | +$249K |
|
|
PSTX
4413
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.65M | ﹤0.01% |
275,990
-263,020
| -49% | -$1.37M |
|
4414
Invesco Equal Weight 0-30 Year Treasury ETF
GOVI
$1.23B
| $2.65M | ﹤0.01% |
97,923
+2,127
| +2% | +$59.3K |
|
|
SBR
4415
Sabine Royalty Trust
SBR
$1.05B
| $2.65M | ﹤0.01% |
40,823
-18,606
| -31% | -$1.17M |
|
4416
FRP Holdings
FRPH
$421M
| $2.64M | ﹤0.01% |
86,049
+11,514
| +15% | +$352K |
|
|
RPC
4417
Ridgepost Capital
RPC
$991M
| $2.63M | ﹤0.01% |
208,823
-59,328
| -22% | -$724K |
|
4418
Ramaco Resources Class A
METC
$649M
| $2.63M | ﹤0.01% |
262,447
-142,774
| -35% | -$1.59M |
|
|
BBUC
4419
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.04B
| $2.63M | ﹤0.01% |
108,402
-15,575
| -13% | -$397K |
|
|
CMPS
4420
Compass Pathways
CMPS
$1.83B
| $2.63M | ﹤0.01% |
695,669
-304,820
| -30% | -$1.55M |
|
4421
VanEck Morningstar International Moat ETF
MOTI
$76.9M
| $2.63M | ﹤0.01% |
86,712
-6,768
| -7% | -$222K |
|
|
RMMZ
4422
RiverNorth Managed Duration Municipal Income Fund II
RMMZ
$126M
| $2.63M | ﹤0.01% |
175,706
-22,111
| -11% | -$350K |
|
4423
Aquestive Therapeutics
AQST
$494M
| $2.62M | ﹤0.01% |
736,889
+65,400
| +10% | +$302K |
|
4424
NET Power
NPWR
$134M
| $2.62M | ﹤0.01% |
247,456
+97,592
| +65% | +$956K |
|
4425
Savers
SVV
$1.88B
| $2.62M | ﹤0.01% |
255,640
-62,362
| -20% | -$620K |
|
Similar funds
Morgan Stanley's Q4 2024 Portfolio in Review
As of Q4 2024, Morgan Stanley held 8,265 positions worth $1.43T, up 3.5% from $1.38T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2024 filing shows 346 new, 3,539 increased, 3,177 reduced and 287 closed positions. Its largest new stake was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2024 buy was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B.
- Morgan Stanley added most to NVIDIA in Q4 2024, an estimated $2.75B increase.
- Morgan Stanley's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.7B.
- Morgan Stanley fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $259M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.43T portfolio in Q4 2024.
- Morgan Stanley opened 346 new positions and closed 287 in Q4 2024.
- Morgan Stanley's portfolio value rose 3.5% quarter-over-quarter to $1.43T.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.